Figure 3. Overall survival for patients with low (≤2) and high (>2) immunoreactive scores for expression of cytoplasmic ligand-dependent co-repressor (LCOR). According to a 60-month follow-up, the OS was longer in patients with high cytoplasmic expression of LCOR. On the contrary, OS in patients with tumors expressing low cytoplasmic LCOR had a poor prognosis.
